Experimental Drug for Rheumatoid Arthritis Shows Promise

THURSDAY, March 31, 2016 — An experimental drug to treat rheumatoid arthritis showed promise in a new six-month trial.
Baricitinib substantially reduced symptoms and improved daily physical functioning among people who failed other treatments for…
Source: Topamax